Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 16/20 | 0.67 |
| ▸ | IDH2 | P48735 | 6/20 | 0.67 |
| ▸ | SYK | P43405 | 2/20 | 0.58 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | KDR | P35968 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29560315 | 0.87 | IDH1 (0.73) | IDH1IDH2SYKABCB11ADORA3 | |
| SCHEMBL15102590 | 0.87 | IDH1 (0.73) | IDH1IDH2SYKABCB11ADORA3 | |
| SCHEMBL21977064 | 0.86 | SYK (0.53) | IDH1IDH2SYK | |
| SCHEMBL29763269 | 0.86 | IDH1 (0.70) | IDH1IDH2SYKABCB11ADORA3 | |
| SCHEMBL15102620 | 0.86 | IDH1 (0.70) | IDH1IDH2SYKABCB11ADORA3 | |
| SCHEMBL15102596 | 0.84 | IDH1 (0.67) | IDH1IDH2ABCB11ADORA3CHRM1 | |
| SCHEMBL29763462 | 0.84 | IDH1 (0.67) | IDH1IDH2ABCB11ADORA3CHRM1 | |
| SCHEMBL15102555 | 0.83 | IDH1 (0.69) | IDH1IDH2SYKABCB11ADORA3 | |
| SCHEMBL15102615 | 0.83 | IDH1 (0.66) | IDH1IDH2SYKABCB11ADORA3 | |
| SCHEMBL15102593 | 0.83 | IDH1 (0.66) | IDH1IDH2SYKABCB11ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3984997-A1 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | Les Laboratoires Servier SAS (FR) | 2022-04-20 | — | — | EP | disclosed |
| EP-2800743-B1 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS INC (US) | 2018-04-04 | — | — | EP | disclosed |